Procainamide Hydrochloride
Product Images NDC 71872-7115

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 71872-7115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7115)

This is a description of a medication called Procainamide HCL Injection, USP. The medication is available in a Multiple Dose Vial containing 1,000mg of Procainamide HCL USP with 100mg/mL of solution. It comes with a warning that it contains metabilsulfite. The medication is sterile and nonpyrogenic and for intravenous or intramuscular use only after dilution. The text advises to use an aseptic technique while handling and indicates the storage temperature range. The dosage instructions are mentioned in an insert. It is manufactured by New Pharmaceuticals, INC. The other part of the text is unreadable.*

FDA Label Image

Structural Formula (Pro0k 0004 01)

FDA Label Image

Principal Display Panel-procainamide HCl 10ml Label (Pro0k 0004 05)

This is a description of a medication called Procainamide HCI that is injected with a 10 mL multiple-dose vial, with each mL containing 100 mg of the active ingredient. The medication is prescribed under Rx Only and contains methylparaben NF and sodium metabisulfite NF. The medication is manufactured for Nexus Pharmaceuticals Inc. The vial should not be used if it is discolored in any way, and the medication contains metabisulfites. The medication should be stored at room temperature which is 20-25°C (68-77℉).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.